CareSens Air achieves maximum 5/5 rating in DSN Forum UK CGM Comparison Chart

Spirit Health and manufacturing partner i-SENS are celebrating CareSens Air achieving the maximum 5/5 study design score in the latest DSN Forum UK CGM Comparison Chart.

 The evidence-based chart has been developed to help nurses and other healthcare professionals compare continuous glucose monitoring (CGM) systems, including the clinical evidence supporting their use in insulin-dosing decisions.

 CareSens Air, developed and manufactured by i-SENS, achieved the maximum rating against the chart’s assessment criteria, which consider key features of CGM systems and the evidence supporting their use for non-adjunctive glucose monitoring.

 Chris Barker, CEO of Spirit Health, said: “Achieving the maximum 5/5 rating in the DSN Forum UK CGM Comparison Chart is an important milestone for CareSens Air and recognition of the quality of the clinical evidence supporting its use.

 “We are incredibly proud of our long-standing partnership with i-SENS and the work that has gone into developing CareSens Air. At Spirit Health, we believe innovative technology has the greatest impact when it is combined with the education and clinical support people need to use it effectively.

 “This recognition reinforces our commitment to making evidence-based diabetes technology more accessible to people living with diabetes and the healthcare professionals supporting them.”

 Spirit Health and i-SENS have worked together since 2009, combining i-SENS’s expertise in glucose monitoring technology with Spirit Health’s understanding of the UK diabetes healthcare landscape.

 CareSens Air provides continuous glucose readings every five minutes for up to 15 days, with data and trends available through the SENS365 platform to support people living with diabetes and their healthcare professionals.

 The updated DSN Forum UK CGM Comparison Chart can be viewed here.

 Further information on CareSens Air can be found here.